Becker's Healthcare July 16, 2019
Andrea Park

To advance the life-saving potential of costly precision cancer treatments, physicians have an obligation to demonstrate the invaluable benefits of those treatments via their work and research, according to Michael Caligiuri, MD, president and physician-in-chief of City of Hope National Medical Center in Duarte, Calif.

In an op-ed for Newsweek, Dr. Caligiuri wrote that while genome sequencing has become more affordable in recent years, “piecing together the elements of the genome that really matter in medicine and matching that learning with carefully designed new biopharmaceuticals and new opportunities for older drugs requires a hefty investment in research.”

It is on physicians, then, to convince payers that the cost is worth it, he wrote. They can do so by...

Today's Sponsors

Qure4u
HLTH
ZeOmega

Today's Sponsors

Premier
TripleTree

Today's Sponsor

Transcarent

 
Topics: Biotechnology, Physician, Precision Medicine, Provider, Technology
Genetic diagnosis of rare diseases up with genome sequencing
GE Healthcare Announces Three New Alliances to Improve Cancer Care
Why Sequencing Covid-19 Is Important During the Pandemic
UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer first
How Precision Medicine and Genetic Testing Will Drive Value-based Care